Global Pharma & Biotech Summit (10-11 November 2026)

 

Global Pharma & Biotech Summit

10 -11 November 2026

In-Person & Digital | Convene 22 Bishopsgate, London, UK

The Global Pharma and Biotech Summit, organised by the Financial Times, brings together the leaders, investors and policymakers shaping the next phase of life sciences. Hear from 60+ expert speakers from organisations including Novartis, GSK, Novo Nordisk, Takeda, Bayer and the Medicines and Healthcare products Regulatory Agency (MHRA) as they explore geopolitical and economic disruption, AI, regulation, market access and the rise of new pharmaceutical innovation hubs.

Hear from leading executives, including:

• Lawrence Tallon, Chief Executive Officer, Medicines and Healthcare Products Regulatory Agency
• Shreeram Aradhye, President, Development, and Chief Medical Officer, Novartis
• Kim Branson, Chief AI Officer, GSK
• Nathalie Moll, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
• Richard Torbett, Chief Executive, Association of the British Pharmaceutical Industry (ABPI)
• Alexander Hardy, President and Chief Executive Officer, BioMarin
• Plus many more

Save 20% off your in-person or digital pass with discount code EUCOPE: tinyurl.com/yx5h24p4